In contrast to the detailed understanding we have for the regulation of skeletal muscle gene expression in embryos, similar insights into postnatal muscle growth and regeneration are largely inferential or do not directly address gene regulatory mechanisms. Muscle stem cells (satellite cells) are chiefly responsible for providing new muscle during postnatal and adult life. The purpose of this study was to determine the role that the myogenic basic helix-loop-helix regulatory factor myogenin has in postnatal muscle growth and adult muscle stem cell gene expression. We found that myogenin is absolutely required for skeletal muscle development and survival until birth, but it is dispensable for postnatal life. However, Myog deletion after birth led to reduced body size implying a role for myogenin in regulating body homeostasis. Despite a lack of skeletal muscle defects in Myog-deleted mice during postnatal life and the efficient differentiation of cultured Myog-deleted adult muscle stem cells, the loss of myogenin profoundly altered the pattern of gene expression in cultured muscle stem cells and adult skeletal muscle. Remarkably, these changes in gene expression were distinct from those found in Myog-null embryonic skeletal muscle, indicating that myogenin has separate functions during postnatal life.
Introduction
The development of vertebrate skeletal muscle begins during embryonic life and is completed after postnatal growth when an animal reaches its adult size. In adults, satellite cells (also referred to as muscle stem cells) recapitulate embryonic myogenesis in a process that adds and repairs existing muscle fibers (Bischoff, 1994; Charge and Rudnicki, 2004; Cossu and Molinaro, 1987; Gibson and Schultz, 1983; Schultz et al., 1985) . During times of muscle stress or injury, quiescent satellite cells residing alongside mature myofibers are activated by external cues to proliferate and differentiate. A recent intense effort in the muscle research community has been to understand and eventually manipulate adult muscle stem cells in ways that will address a wide range of physiological and pathological problems (Kuang and Rudnicki, 2008) .
Once embryonic myogenic precursor cells are specified to the myogenic lineage by the expression of the paired-box transcription factors Pax3 and Pax7, the four basic helix-loop-helix (bHLH) myogenic regulatory factors (MRFs), Myf5, MyoD, myogenin, and Mrf4, begin to orchestrate skeletal muscle development. MRFs cooperate in a synergistic manner with the MEF2 class of proteins for efficient activation of skeletal muscle target genes (Black and Olson, 1998) . Likewise, adult muscle stem cell differentiation also appears to be controlled by the MRFs. Much progress has been made in distinguishing the roles of individual MRF family members from each other. While there is a functional redundancy found among the MRFs, each is conserved among vertebrates and remains efficiently expressed during muscle stem cell proliferation and differentiation (Sabourin and Rudnicki, 2000) . Myf5, MyoD, and Mrf4 function in the activation of muscle stem cells from the quiescent state and promote the expression of target genes necessary for muscle stem cell proliferation (Kablar et al., 1998; Kassar-Duchossoy et al., 2004; Rudnicki et al., 1993) . The differentiation and fusion of embryonic myoblasts into multinucleated fibers involves myogenin, MyoD, and Mrf4 (Berkes and Tapscott, 2005; Charge and Rudnicki, 2004) , although it is not yet clear whether these factors have the same role in adult muscle stem cell differentiation. The genes for each MRF have been knocked out individually and in combination with other family members. Notably, Myog-knockout mice exhibit perinatal lethality caused by a severe disruption of myoblast differentiation and failure to form normal myofibers (Hasty et al., 1993; Nabeshima et al., 1993) . For postnatal survival, Myog expression levels must equal or exceed the heterozygous threshold (Venuti et al., 1995; Vivian et al., 1999) .
Although myogenin is required for the development of functional skeletal muscle, it is not required for the expression of all muscleexpressed genes (Venuti et al., 1995) . Furthermore, the expression of the remaining MRF family members cannot compensate for the lack of myogenin (Rawls et al., 1995) . In a recent study, we analyzed the gene expression profile of myogenin target genes in embryonic tongue muscle. The results demonstrated that the expression of many genes that depend on the presence of myogenin are structural components of the Z-line, which serves as a critical anchor point of the sarcomere, the basic contractile unit of skeletal muscle (Davie et al., 2007) . These results suggest myogenin is necessary for efficient activation of target genes required for terminal differentiation. Furthermore, MyoD or Myf5, which are expressed at normal levels in Myog-knockout embryonic tongue muscle, cannot efficiently activate myogenin-dependent genes.
To investigate myogenin's role in postnatal muscle growth, we generated Myog conditional knockout mice in which efficient deletion was achieved by tamoxifen-mediated activation of a Cre-ER transgene (Hayashi and McMahon, 2002; Knapp et al., 2006) . When Myog was deleted at embryonic day 17.5 (E17.5), surviving postnatal mice lacking myogenin exhibited no apparent defects in muscle morphology or histology. However, half of all Myog-deleted mice died at birth for unknown reasons, and the surviving mice were smaller (Knapp et al., 2006) .
In order to better understand the process of skeletal muscle growth and repair during postnatal and adult life, it is essential to precisely define the genetic program under the control of the MRFs during muscle stem cell proliferation and differentiation. The aim of this study was to clarify myogenin's role in perinatal and postnatal life, particularly in postnatal muscle growth, and identify the genes whose expression is controlled by myogenin in adult muscle stem cells. We show here that myogenin is absolutely essential for skeletal muscle development and viability until just before birth. However, when Myog was deleted 1 day after birth (P1), the mice survived and we saw no overt muscle abnormalities, although as observed earlier, Myogdeleted mice were significantly smaller, suggesting a role for myogenin in regulating body homeostasis. Although skeletal muscle was superficially normal, major changes in the expression of muscle genes were found in adult muscle stem cells and muscle of Myogdeleted mice. Remarkably, these changes in gene expression were quite different from those identified in embryonic tongue muscle. The results confirm and extend our hypothesis that myogenin has distinct functions as a transcriptional regulator in embryonic myogenesis and postnatal muscle growth.
Materials and methods

Generation of Myog-deleted mice
The mouse line used for the project was homozygous for the Myog flox allele and hemizygous for the CAGGCre-ER transgene (Hayashi and McMahon, 2002; Knapp et al., 2006) . These mice were of mixed background, containing both 129 and C57BL/6 strains. All injections were performed once using tamoxifen (Sigma) at a concentration of 3 mg/40 g body weight. Pregnant females were injected intraperitoneally (IP) at either E16.5 or E18.75 of pregnancy. For postnatal Myog deletion, new born pups at P1 were injected IP. Weights were measured daily between P5 and P22 and weekly thereafter. All animal procedures in this study followed the U.S. Public Health Service Policy on Humane Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee at The University of Texas M. D. Anderson Cancer Center.
Histology and fiber area measurement
New-born mice were embedded in paraffin and sectioned for hematoxylin and eosin staining using previously described methods (Knapp et al., 2006) . Hind limb muscle was used for fresh-frozen sections by snap freezing the tissue in LN 2 -cooled isopentane and sectioning at 10-12 µm with a Cryostat. Student's unpaired t-tests were performed to determine p-values. Images were taken on a microscope (Olympus IX70) with an Olympus UPlanApo 10×/0,40 objective lens and camera (Olympus DP71) with Olympus DP-Controller software. Myofiber areas were measured with NIH ImageJ Software (Abramoff et al., 2004) . All muscle fibers visible at 100× magnification using gastrocnemius and tibialis anterior muscles from 6-week-old mice were measured and the mean and standard deviations calculated.
DNA isolation and genotyping
DNA was phenol-chloroform extracted from tail or muscle samples. PCR was performed using the Qiagen HotStarTaq kit on an ABI Gene AMP PCR system model 9700. Q-PCR was performed using ABI SYBR mix on an ABI 7500 Fast Real Time PCR system. DNA Primers and PCR conditions used for genotyping may be obtained by contacting the corresponding author.
Isolation of muscle stem cells from hind limbs
Muscle stem cells were isolated from hind limb muscle from 6 mice (Myog flox/flox ; Cre-ER + ) 6 to 8 weeks of age using a protocol from the Pavlath Lab (www.pharm.emory.edu/gpavlath/protocols/ MPCprep0505.pdf). The cells with round morphological characteristics were selected and defined as primitive muscle stem cells (satellite cells). Images were taken on using a microscope (Leica DMIL) with a Leica CPlan 10×/0.22 PH1 objective lens and camera (Canon Digital Rebel XT) with Adobe Photoshop 9.0 software.
Cell culture and tamoxifen treatment
Myog flox/flox ; Cre-ER + muscle stem cells were grown to approximately 75% confluence on a 10 cm plate. Cells proliferated in the presence of 20% Qualified FBS (Gibco) and 2.5 ng/ml human bFGF (Sigma). The cells were then split evenly into 2 new collagen-coated plates using F-10 growth media. After 24-48 h, the cells attached to the plates and reached 50% confluence. 4-hydroxy-tamoxifen (4-OHT, Sigma-Aldrich) was added to fresh growth media to a final concentration of 5 µM 4-OHT, and the cells were incubated for 48 h. Prior to analysis, the 4-OHT solution was removed and fresh media added to allow the cells 24 h for treatment recovery. Muscle stem cells were induced to differentiate by replacing the growth media with low-serum differentiation media (DMEM supplemented with 2% horse serum).
Immunofluorescence
Immunofluorescence was performed on muscle stem cells and NIH-3T3 fibroblast cells and images were collected on an Olympus FluoView 1000 Confocal Microscope (Olympus IX70) with a UPlanFI 10×/0.30 PH1 objective lens and Olympus FluoView 1000 software. Controls in which the primary antibody was omitted were used for each cell line. The cells were cultured for at least 24 h. The slides were rinsed in PBS, fixed with 4% para-formaldehyde for 30 min, washed with PBS for 3 × 5 min, and then permeabilized with PBST (0.5% Triton X-100 in PBS) for 10 min. After washing in PBS, the cells were treated with 2% BSA (in PBST) for 1 h. The primary antibody was then added at a dilution of 1:200 in PBS for 1 h. Primary antibodies used were c-Met (Santa Cruz), desmin (Zymed), M-cadherin (Santa Cruz), myogenin (Santa Cruz), MyoD (Santa Cruz), Pax3/7 (Santa Cruz), and Mhc (Zymed). The cells were again washed with PBS for 3 × 5 min and secondary antibody was then added at 1:400 dilution in PBS for 1 h. Secondary antibodies used were Cy3 anti-mouse (Jackson Immuno), Cy5 anti-rabbit (Jackson Immuno), and Alexa488 anti-goat (Molecular Probes). After incubation with secondary antibody, the cells were washed with PBS for 3 × 10 min, and Aqua-Mount was used to mount the cover slip.
RNA isolation and qRT-PCR
RNA was isolated from semi-confluent muscle stem cell lines using either an Invitrogen Trizol protocol or a Qiagen RNeasy Plus kit protocol. Each 10 cm plate consistently yielded approximately 30-50 µg of RNA. Hind limb tissue was isolated using the Qiagen RNeasy Plus kit protocol. Reverse transcription and quantitative PCR were performed as described previously (Davie et al., 2007) . The PCR primers used for detecting the transcripts are available by contacting the corresponding author. Primers were designed using PrimerBank (http://pga.mgh.harvard.edu/primerbank). Student's t-tests were used to determine significance between two groups. Statistical analysis was performed in Microsoft Excel 2003. For all statistical tests, a confidence level of p b 0.05 was accepted as statistically significant. One standard deviation from the mean was determined for all comparisons.
Affymetrix gene microarray hybridization and analysis
RNA was isolated from the Myog-deleted and wild-type muscle stem cells after 48 h of differentiation. Five micrograms of total RNA from each sample was used for preparing hybridization probes. Three independent samples were used in standard Affymetrix protocols to yield fluorescently labeled cRNA fragments, which were hybridized to Mouse Genome 430 2.0 GeneChips (Affymetrix). The hybridized GeneChips were scanned using an Affymetrix GeneArray scanner, and the raw image files were analyzed using the ArrayAssist 4.0 software program (Stratagene) with probe logarithmic intensity error normalization (Katz et al., 2006) . Unpaired two-class t-tests were performed without error stabilization or p-value correction and p-value cutoffs were set at p b 0.05. From the filtered data set, all genes changing ≥1.7 fold were kept for further analysis.
In situ hybridization
Twelve-micron fresh-frozen sections were obtained from hind limb tissue samples dissected from 6-week-old wild-type and Myogdeleted mice. To generate probes, cDNAs for Adamts5, Sema3d, and Socs3 (Fantom Clones, Dnaform/Riken) were digested as follows: Adamts5 (T7), PvuI/NspI; Adamts5 (T3), EagI/PvuI; Sema3d (T7), PvuI/ BamHI; Sema3d (T3), ApaLI/SacII; Socs3 (T7), PvuI/BamHI; Socs3 (T3), AccI/SspI. Probes for Myog, Ldb3, and Lmod2 were generated as described previously (Davie et al., 2007) . The linearized products were subsequently transcribed in vitro using T3 RNA polymerase (antisense probe) and T7 RNA polymerase (sense probe) in the presence of digoxigenin (Boehringer-Mannheim, Germany). Nonradioactive in situ hybridization was performed to detect spatial expression as described previously (Lee et al., 2000) . Images were taken on using a microscope (Olympus IX70) with an Olympus UPlanApo 10×/0,40 objective lens and camera (Olympus DP71) with Olympus DP-Controller software.
Statistical analysis
Student's t-tests were used to determine significance between two groups. Statistical analysis was performed in Microsoft Excel 2003. For all statistical tests, a confidence level of p b 0.05 was accepted as statistically significant. One standard deviation from the mean was determined for all comparisons.
Results
Myogenin is required for normal perinatal development
We had previously observed that when Myog was deleted at E17.5, only 50% of the mice with a Myog-deleted genotype were born (Knapp et al., 2006) . To determine why so many Myog-deleted mice were not surviving, pregnant females were injected with tamoxifen at E16.5 and E18.75, and caesarean sections were performed at E19.5. When tamoxifen was injected intraperitoneally (IP) at E16.5 and fetuses were collected at E19.5, approximately half of the pups from each litter died within 10 min (Figs. 1A, E). Virtually all of the pups that died harbored the Cre-ER transgene in their genomes while most of the surviving pups did not (wild-type n = 53; Myog-deleted n = 57). Quantitative PCR genotyping of tail clippings indicated that genomic deletion of Myog in the dead pups averaged 95% (n = 12). Data obtained from our previous study indicated that Myog deletion levels in tail clippings and skeletal muscle tissue were very similar (Knapp et al., 2006) . The few surviving Myog-deleted animals were severely growth-stunted and died within 2 weeks of birth. Similar results were obtained with the E18.75 tamoxifen treatment (data not shown).
Histological analysis of skeletal muscle from new born (P0) dead pups and their surviving littermate controls revealed a severe impairment of skeletal muscle development in the Myog-deleted pups. Muscles from the diaphragm, deep back, and intercostal ribs were significantly less developed relative to wild-type littermate controls (Figs. 1B-D, F-H). Myog-deleted pups gasped for air and responded to pain stimulation similar to littermate controls, but did not survive beyond 10 min post-caesarean section likely due to severe diaphragm defects. While Myog-deleted and control P0 pups had approximately the same body weight and organ size, skeletal muscle size was reduced dramatically (Figs. 1B-D, F-H). The results extend our previous analyses (Knapp et al., 2006; Venuti et al., 1995) and show that an absolute requirement for myogenin extends until just before birth. The results account for the high lethality rate observed in mice when Myog is deleted at late stages of myogenesis, between E16.5 and E18.75. This is a time when secondary myogenesis is underway, and the results indicated that this period is extremely sensitive to the presence of myogenin (Venuti et al., 1995; Wigmore and Dunglison, 1998) .
Myogenin is required for achieving normal body size but not for skeletal muscle growth during postnatal life
We next IP-injected tamoxifen into 1 day old (P1) pups. The pups we injected were visibly healthy and suckled normally as indicated by the presence of milk in their stomachs. We routinely observed efficient deletion of Myog within 48-72 h after tamoxifen injection (Knapp et al., 2006) . By P5, all injected pups appeared healthy, and approximately half had genotypes indicating that, on average, 80% of Myog DNA was deleted from tail genomic DNA. Genomic DNA levels of Myog in tail samples were similar to those of hind limb muscle (data not shown) and served as a viable indicator of Myog deletion efficiency. We did not determine whether all skeletal muscle tissues were equal in efficiency for deletion events, but deletion events were highly similar in tongue tissue (data not shown). Between P5 and P22, postnatal Myog-deleted pups did not gain weight at the same rate as their littermate controls, and by P22, their average body weight was 20% less than in wild-type controls (wild-type n = 46, Myog-deleted n = 33) ( Fig. 2A ). By 6 weeks of age (P42), the postnatal Myog-deleted animals averaged 37% less body mass than wild-type littermates (wild-type n = 4, Myog-deleted n = 4) (Fig. 2B) . These results were consistent with those of our previous study and suggested that myogenin plays an indirect role in regulating overall body homeostasis.
Gastrocnemius and tibialis anterior muscles from postnatal Myogdeleted mice and wild-type controls were examined at P42. Myog transcript levels in hind limb muscle isolated from the Myog-deleted mice were, on average, 7% of those in the same muscle from wild-type mice, as determined by quantitative reverse transcriptase-PCR (qRT-PCR) (Fig. 2C ). Histological analysis of Myog-deleted hind limb muscle revealed significantly smaller myofibers that appeared to organize and fuse normally with cross-sectional areas reduced by 26% in the gastrocnemius and tibialis anterior muscles of Myog-deleted mice relative to those of wild-type littermates (Figs. 2D-F) . This reduction might be expected, since all organs in Myog-deleted mice were proportionally reduced in size. However, we have not determined whether the reduced size in other organs was caused by fewer cells or alternatively, that individual cells were smaller.
Deletion of Myog from adult muscle stem cells
We next determined whether the deletion of Myog in adult muscle stem cells affected their ability to differentiate into skeletal muscle or altered their pattern of gene expression. Adult mice between 6 and 8 weeks of age were sacrificed and hind limb muscle was used for muscle stem cell isolation. The cells were characterized with the muscle stem cell-specific markers Pax7, desmin, c-Met, and M-cadherin to confirm their origins (Allen et al., 1991; Cornelison and Wold, 1997; Seale et al., 2000) (Fig. S1 ). To delete Myog, we used the Cre-Lox system; muscle stem cells were treated with 4-hydroxy- tamoxifen for 24 h. This procedure led to a 91% deletion of Myog (Fig.  S2 ) and a 91% reduction in Myog transcripts (Fig. 3C) .
Myog-deleted muscle stem cells proliferated in culture at the same rate as wild-type cells (data not shown). Relative expression levels of Myf5, MyoD, and Mrf4 were analyzed in proliferating wild-type and Myog-deleted cells. Myf5, MyoD, and Mrf4 showed no significant change in transcript levels despite the large reduction of Myog transcript levels (Fig. 3C) . These results suggested that Myf5, MyoD, and Mrf4 transcripts were not compensating for the lack of myogenin as muscle stem cells proliferated in culture.
When wild-type and Myog-deleted muscle stem cells were induced to differentiate into myotubes, all cell lines that we tested differentiated normally compared with control cells of the same genotype but not treated with tamoxifen. Efficient differentiation was observed in all the muscle stem cell lines that were established, indicating that neither the loss of myogenin nor treatment with tamoxifen affected differentiation (Figs. 3A, B) . These results were consistent with prior studies that showed Myog-null embryonic myoblasts differentiate normally in culture (Hasty et al., 1993; Nabeshima et al., 1993) .
Immunofluorescence was performed on the muscle stem cells after 48 h of differentiation to further determine the efficiency of differentiation. In Myog-deleted cells, myogenin protein expression was significantly reduced while the expression of MyoD and desmin, an indicator of differentiation efficiency at the subcellular level, remained unchanged (Fig. S3 ).
The relative expression levels of Myf5, MyoD, and Mrf4 were analyzed in differentiating muscle stem cells. Myog is normally upregulated at 48 h in embryonic myoblasts differentiating in culture (Cornelison and Wold, 1997) . However, the absence of myogenin at this critical time point did not affect differentiation, suggesting that other factors were compensating for the loss of myogenin, perhaps the remaining MRFs. At 48 h, Myog transcripts in the Myog-deleted cells were expressed at approximately 14% of the levels found in wild-type controls. Myf5 and Mrf4 were upregulated approximately 2 fold and MyoD was upregulated approximately 1.6 fold (Fig. 3D) . These results suggest that compensatory mechanisms may be activated by the remaining MRFs in the absence of myogenin.
Myogenin is required for efficient expression of many novel genes expressed during muscle stem cell differentiation
Target genes for myogenin in adult muscle stem cell derivatives were identified by Affymetrix microarray analysis using probes from Myog-deleted and control muscle stem cells at 48 h of differentiation. The gene set generated from the analysis contained 71 downregulated genes and 191 upregulated genes with p-values b 0.05 and fold changes ≥1.7 (Table S1 ). Analysis with Array Assist 4.0 revealed that the expression of typical muscle structural and contractile genes was unaltered in Myog-deleted cells. This result might be anticipated since in the absence of myogenin, the cells differentiated efficiently into seemingly normal myotubes. However, it is very different from what we observed with Myog-null embryonic tongue muscle, where most genes encoding structural and contractile components were strongly downregulated.
The expression of selected highly deregulated genes, nine downregulated genes and seven upregulated genes, was further evaluated by qRT-PCR for a more accurate quantitative assessment of expression levels. All of the downregulated genes selected from the microarray analysis were confirmed as downregulated (Fig. 4) . These genes included those encoding Adamts5 (Schlondorff and Blobel, 1999) , Alcam (van Kempen et al., 2001) , CD24a (Figarella-Branger et al., 1993; Jevsek et al., 2006) , Hdac11 (Gao et al., 2002) , Itga4 (Yang et al., 1996) , Ptgis (Bondesen et al., 2007; Prisk and Huard, 2003) , Sema3d (Kruger et al., 2005) , Socs3 (Spangenburg, 2005) , and Sdpr (Gustincich and Schneider, 1993) . A description of these genes is provided in Table 1 .
The expression levels of selected upregulated genes were also determined by qRT-PCR (Fig. S4) . These genes include Ckmt2 (Kernec et al., 2001; Schlattner et al., 2006) , Id1, Id2, Id3 (Ruzinova and Benezra, 2003) , integrin beta 1 binding protein 3 (Li et al., 1999) , Mef2c (Martin et al., 1993) , and Spp1/osteopontin (Bayless et al., 1998; Hirata et al., 2003) (Table 1 ). The genes encoding Ckmt2, integrin beta 1 binding protein 3, Mef2c, and Spp1/osteopontin were confirmed to be upregulated by this approach. However, the genes encoding Id1, Id2, and Id3 were not, leaving open the question of the biological significance of their upregulation in the microarray analysis.
We extended our analysis by determining whether the expression of genes found to be downregulated in cultured Myog-deleted muscle stem cell derivatives were also downregulated in adult skeletal muscle tissue, in vivo. In situ hybridization analysis was performed using hind limb muscle from 6-week-old wild-type and Myog-deleted mice. Antisense probes were generated for Adamts5, Sema3d, and Socs3, three downregulated genes discovered in the microarray analysis. Myog was included as a control. We also used probes against Lmod2 and Ldb3, two genes previously identified as downregulated in Myognull embryonic tongue muscle but were not downregulated in cultured adult muscle stem cell derivatives (Davie et al., 2007) . Myog, Adamts5, Sema3d, and Socs3 were all strongly downregulated in Myog-deleted hind limb muscle while Lmod2 and Ldb3 showed no changes in gene expression (Fig. 5) . These results indicated that myogenin was regulating distinct gene sets in embryonic versus adult skeletal muscle.
Discussion
Myogenin's role as a critical regulator of skeletal muscle differentiation and myocyte fusion has been well documented. The present study, together with previous work, defines more precisely the period during embryonic and fetal life when the loss of myogenin leads to muscle deficiency and lethality (Fig. 6 ). Our results extend earlier studies to show that myogenin is needed until just before birth. Skeletal muscle development during the late stages of fetal development largely involves the maturation of myofibers, innervation, and overall muscle growth; these events cannot take place normally without myogenin. In notable contrast, we found that immediately following birth, the absence of myogenin had no substantial impact on the morphology or relative growth of skeletal muscle (Fig. 6 ). Because we deleted Myog within 24 h after birth, the complications associated Table S1 and descriptions are given in Table 1 . ⁎p b 0.05. with the requirement for myogenin during embryonic and fetal development were avoided. These results, therefore, provide a direct demonstration that myogenin is dispensable for skeletal muscle growth and survival during postnatal life, a period when the rate of increase in muscle mass is intense. The findings are particularly striking because skeletal muscle mass increases over 10 fold during the first 6 weeks of postnatal life. However, reduced body size was routinely associated with Myog-deleted mice, suggesting that myogenin is affecting overall body homeostasis. Because Myog expression is restricted to the skeletal myogenic lineage, this result implies that myogenin is playing an indirect role in homeostasis by regulating the production of skeletal muscle-derived extrinsic factors.
Our study also provides new insights into the role of myogenin in adult muscle stem cells. When Myog-deleted adult muscle stem cells were induced to differentiate, an upregulation of Myf5, MyoD, and Mrf4 transcripts were observed. While these results do not directly demonstrate that the other MRFs were compensating for myogenin's loss, the fact that they were significantly upregulated suggested that they could be replacing some of myogenin's functions in regulating muscle gene expression; their increased levels would promote their ability to bind to myogenin target genes. This finding is potentially interesting as it differs from the results obtained using tongue myocytes in our previous study (Davie et al., 2007) and is consistent with the notion that myogenin has different functions during adult versus embryonic life. Although Myog-deleted muscle stem cells proliferate and differentiate in culture as efficiently as wild-type cells, myogenin was nonetheless found to regulate a distinct set of muscleexpressed genes. The expression of these myogenin-dependent genes was dramatically altered in the absence of myogenin. Unlike what was observed with embryonic myoblasts, many of the myogenin-dependent genes in Myog-deleted adult muscle stem cells encode factors involved in cell fusion, innervation, or are membrane-associated or secreted proteins (Tables 1 and S1). We found very few myogenindependent genes encoding structural or contractile proteins. It is remarkable that although skeletal muscle differentiation proceeds unabated in cultured muscle stem cells, and skeletal muscle growth is seemingly normal in postnatal life, the muscle gene expression program is profoundly altered in the absence of myogenin.
Although our experiments determined the gene expression profiles in muscle stem cells derived from adult mice 6-8 weeks of age, it is likely that the myogenin-dependent genes we identified are the same as those in younger, still-growing mice. The altered expression of some of these genes at times of active muscle growth could compromise muscle stem cell function in ways that cause reduced body size. Compromised muscle stem cell function does in fact lead to a 77% size reduction in Pax7-null animals by 2 weeks of age, a 33% reduction in myofiber diameters, and results ultimately in lethality (Seale et al., 2000) .
Many of the myogenin-dependent genes identified in the microarray analysis encode proteins with functions that provide insights into myogenin's role in postnatal skeletal muscle growth. A summary of these genes and their functions is provided in Table 1 . For example, Adamts5 is a secreted protease that regulates events on or near the cell surface and at a distance (Nagase and Kashiwagi, 2003; Schlondorff and Blobel, 1999; Stanton et al., 2005) . It was recently found to be the major aggrecanase in mouse cartilage, playing a role in aggrecan loss and cartilage erosion in a mouse model of inflammatory arthritis (Stanton et al., 2005) . Myogenin may play a role in the production of Adamts5 and the regulation of cartilage homeostasis during adult life. Alcam contains immunoglobulin-like domains that regulate complex cellular properties in cell adhesion, growth, and migration. These adhesion molecules play important roles in development and homeostasis (van Kempen et al., 2001) . CD24 is a signal transducing molecule and a marker for human regenerating muscle (Figarella-Branger et al., 1993; Jevsek et al., 2006) . Socs3 regulates cytokines and growth factors (Alexander and Hilton, 2004) and induces myoblast differentiation (Spangenburg, 2005) . Socs3 expression is partly induced by the activation of the IGF-I receptor during myoblast differentiation (Spangenburg, 2005) . It is possible that myogenin cooperates with IGF-I to regulate Socs3 expression in newly developing adult myofibers. It would not be surprising if myogenin and IGF-I had overlapping functions with respect to Socs3, as IGF-I is a well-described regulator of skeletal muscle development (Benito et al., 1996; Kuninger et al., 2004; Spangenburg et al., 2006) . Perhaps one of the most interesting downregulated genes is Ptgis (prostaglandin I 2 synthase). Prostaglandins are involved in the repair of muscle injuries (Prisk and Huard, 2003) , and PGI 2 (prostaglandin I 2 ) enhances myoblast fusion in vitro (Pavlath and Horsley, 2003; Bondesen et al., 2004 Bondesen et al., , 2007 . We previously found that myogenin has direct roles in myoblast fusion (Myer et al., 1997) . Myogenin may control the transcription of Ptgis, which regulates PGI 2 synthesis, ultimately enhancing myoblast fusion and muscle repair. Myogenin also upregulates the expression of genes whose encoded proteins are involved in regulating the energy state of the developing myofiber and in muscle regeneration. Genes encoding proteins with these functions are described in Table 1 .
The mechanistic explanation for the very different functions for myogenin before and after birth remains unresolved. While it is possible that these differences are attributed to our comparison of different muscle groups (tongue versus hind limb), their similar structural features and functions suggest that they are subject to comparable developmental regulatory mechanisms. It is possible that myogenin has critical functions in adult life that will only be revealed when Myog-deleted mice and Myog-deleted muscle stem cells are placed under conditions of muscle stress and trauma, which may demand stronger gene regulatory responses from the muscle stem cell population than those of mice under no muscle stress.
